MedDataX Logo

Outcome of Patients Undiagnosed Under Medical Thoracoscopy

NCT ID: NCT01356979

Last Updated: 2012-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

355 participants

Study Classification

OBSERVATIONAL

Study Start Date

2002-02-28

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Medical thoracoscopy (MT) under local anaesthetic and mild sedation, an established method in the diagnosis of pleural diseases. MT has an overall diagnostic yield above 90% for malignant pleural diseases and pleural tuberculosis. However, others who are diagnosed as fibrinous pleuritis make confusion in clinicians. Whether these patients are firmly followed or not ? The investigators do not know the answer of this question.

In this study the investigators aimed to investigate the outcome of the patients who are diagnosed as fibrinous pleuritis on MT biopsies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Medical thoracoscopy (MT) under local anaesthetic and mild sedation, an established method in the diagnosis of pleural diseases with a sensitivity above 90% and specificity of 1000% for malignant pleural diseases and pleural tuberculosis. Except these two groups of patients, in others pleural histopathological diagnosis is defined as "non-specific pleuritis" or "fibrinous pleuritis". Authors say that the natural evolution of these patients is poorly understood. Some of these patients was later established false negative cases for malignant pleural diseases. Clinical guidelines recommend close observation of patients with undiagnosed exudative effusions, although the length and follow-up regime is not defined, yet. In this study the investigators examine the outcome of patients who are diagnosed as fibrinous pleuritis by MT.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pleural Diseases

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Medical thoracoscopy Pleural effusion Malignant pleural diseases Tuberculous pleuritis Fibrinous pleuritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients underwent medical thoracoscopy

Patients who require medical thoracoscopy for undiagnosed exudative pleural effusion by other clinical or radiological investigations.

Medical thoracoscopy

Intervention Type PROCEDURE

Performing medical thoracoscopy to diagnose pleural diseases after cytological and other investigational tests.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medical thoracoscopy

Performing medical thoracoscopy to diagnose pleural diseases after cytological and other investigational tests.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Rigid thoracoscopy for diagnosis of pleural diseases

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Undiagnosed exudative pleural effusion
* Under 20 years-old, over 85 years-old
* Followed 2 years at least

Exclusion Criteria

* Transudative pleural effusion
* Patients who do not accepted medical thoracoscopy.
Minimum Eligible Age

20 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eskisehir Osmangazi University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Muzaffer Metintas

MD, Prof. in Pulmonary Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Muzaffer Metintas, MD

Role: PRINCIPAL_INVESTIGATOR

ESOGU Medical Faculty Department of Chest Diseases

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ESOGU Medical Faculty Department of Chest Diseases

Eskişehir, Meselik - Eskisehir, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

052011/15

Identifier Type: -

Identifier Source: org_study_id